Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

External Therapy for Tinnitus Management

NCT: NCT07017998 · RECRUITING

NCT IDNCT07017998
StatusRECRUITING
Start Date2025-07-16
Completion2027-12-01
SponsorRestorear Devices LLC (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this remote interventional clinical study is to investigate the use of mild therapeutic hypothermia devices for the symptomatic relief of chronic tinnitus. The main aims of the study are: 1. Ascertain the effects of MTH in chronic tinnitus patients using questionnaires measuring tinnitus severity and intervention-related change. 2. Ascertain the comfort and acceptability of the hypothermia device and therapy. Participants with chronic tinnitus will wear the mild therapeutic hypothermia therapy devices for a single 30 minute session. Researchers will compare results from those receiving therapy to those from a control group.

Frequently Asked Questions

What is External Therapy for Tinnitus Management?

External Therapy for Tinnitus Management is a clinical trial registered under NCT07017998. Current status: RECRUITING.

What is the status of NCT07017998?

The current status of NCT07017998 (External Therapy for Tinnitus Management) is: RECRUITING.

When did External Therapy for Tinnitus Management start?

External Therapy for Tinnitus Management started on 2025-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.